|
05 Jan 2017 |
Synthetic Biologics' SYN-004 (ribaxamase) Achieves Primary Endpoint in Phase 2b Trial for C. difficile Infection (CDI)
|
|
05 Jan 2017 |
XTL Biopharmaceuticals' Preclinical Studies of hCDR1 Demonstrate Therapeutic Potental In the Treatment of Sjögren's Syndrome
|
|
05 Jan 2017 |
Novaliq Announces Positive Topline Results of Phase 2 Clinical Trial Evaluating CyclASol® in Adults with Moderate to Severe Dry Eye Disease
|
|
05 Jan 2017 |
Halozyme Announces Phase 2 Study In Advanced Pancreas Cancer Meets Key Endpoints
|
|
05 Jan 2017 |
Aeterna Zentaris Announces Top-Line Results of Confirmatory Phase 3 Trial of Macrilen™
|
|
04 Jan 2017 |
Tarveda Therapeutics Announces Phase 1/2a Clinical Trial of PEN-221 Underway in Patients with Neuroendocrine Tumors and Small Cell Lung Cancer
|
|
04 Jan 2017 |
Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera™ for Treatment of Dry Eye
|
|
01 Jan 2017 |
OPKO Health Provides Update on hGH-CTP Clinical Programs
|
|
29 Dec 2016 |
Anthera Announces the Phase 3 SOLUTION Study with Sollpura™ in Cystic Fibrosis Patients with Exocrine Pancreatic Insufficiency Demonstrates Encouraging Results - Additional Study Needed
|
